{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T03:09:24Z","timestamp":1762139364486,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972550"],"award-info":[{"award-number":["81972550"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017577","name":"Zhejiang Province Basic Public Welfare Research Program","doi-asserted-by":"publisher","award":["LGF18H160030","Y2100660"],"award-info":[{"award-number":["LGF18H160030","Y2100660"]}],"id":[{"id":"10.13039\/501100017577","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Environmental Research"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.envres.2023.116895","type":"journal-article","created":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T11:03:26Z","timestamp":1692011006000},"page":"116895","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Novel affibody molecules as potential agents in molecular imaging for MAGE-A3-positive tumor diagnosis"],"prefix":"10.1016","volume":"237","author":[{"given":"Yiqi","family":"Cai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahuan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinji","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanyi","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peipei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengfei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanli","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanbao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lifang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.envres.2023.116895_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/0256-4947.75771","article-title":"18F-FDG PET\/CT imaging in oncology","volume":"31","author":"Almuhaideb","year":"2011","journal-title":"Ann. Saudi Med."},{"key":"10.1016\/j.envres.2023.116895_bib2","doi-asserted-by":"crossref","DOI":"10.1177\/1536012118823473","article-title":"Analysis of progress and challenges of EGFR-targeted molecular imaging in cancer with a focus on Affibody molecules","volume":"18","author":"Chen","year":"2019","journal-title":"Mol. Imag."},{"key":"10.1016\/j.envres.2023.116895_bib3","series-title":"Molecular Imaging and Contrast Agent Database (MICAD)","article-title":"18F-Labeled Cys-ZHER2:342, an anti-epidermal growth factor receptor-2 Affibody","author":"Chopra","year":"2012"},{"key":"10.1016\/j.envres.2023.116895_bib4","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.molcel.2010.08.029","article-title":"MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases","volume":"39","author":"Doyle","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.envres.2023.116895_bib5","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S1470-2045(18)30254-7","article-title":"MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial","volume":"19","author":"Dreno","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.envres.2023.116895_bib6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/protein\/gzm011","article-title":"Phage display selection of Affibody molecules with specific binding to the extracellular domain of the epidermal growth factor receptor","volume":"20","author":"Friedman","year":"2007","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.envres.2023.116895_bib7","doi-asserted-by":"crossref","first-page":"8200","DOI":"10.3748\/wjg.v23.i46.8200","article-title":"Early gastric cancer frequently has high expression of KK-LC-1, a cancer-testis antigen","volume":"23","author":"Futawatari","year":"2017","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.envres.2023.116895_bib8","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1177\/1430.15817","article-title":"Clinical significance of immunohistochemical expression of cancer\/testis tumor-associated antigens (MAGE-A1, MAGE-A3\/4, NY-ESO-1) in patients with non-small cell lung cancer","volume":"100","author":"Grah","year":"2014","journal-title":"Tumori"},{"key":"10.1016\/j.envres.2023.116895_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-74560-5","article-title":"Increasing thermal stability and improving biodistribution of VEGFR2-binding Affibody molecules by a combination of in silico and directed evolution approaches","volume":"10","author":"G\u00fcler","year":"2020","journal-title":"Sci. Rep."},{"issue":"Suppl. ment","key":"10.1016\/j.envres.2023.116895_bib10","doi-asserted-by":"crossref","first-page":"C271","DOI":"10.4103\/0973-1482.170549","article-title":"Evaluation of melanoma antigen gene A3 expression in drug resistance of epidermal growth factor receptor-tyrosine kinase inhibitors in advanced nonsmall cell lung cancer treatment","volume":"11","author":"Jin","year":"2015","journal-title":"J. Cancer Res. Therapeut."},{"key":"10.1016\/j.envres.2023.116895_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.784925","article-title":"Comprehensive analysis to identify MAGEA3 expression correlated with immune infiltrates and lymph node metastasis in gastric cancer","volume":"11","author":"Jin","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.envres.2023.116895_bib12","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1200\/JCO.2012.43.7111","article-title":"Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European organisation for research and treatment of cancer melanoma group in metastatic melanoma","volume":"31","author":"Kruit","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.envres.2023.116895_bib13","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1016\/j.febslet.2010.04.014","article-title":"Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications","volume":"584","author":"L\u00f6fblom","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.envres.2023.116895_bib14","doi-asserted-by":"crossref","first-page":"5667","DOI":"10.1038\/s41467-020-19498-y","article-title":"Co-administered antibody improves penetration of antibody\u2013dye conjugate into human cancers with implications for antibody\u2013drug conjugates","volume":"11","author":"Lu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.envres.2023.116895_bib15","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/protein\/8.6.601","article-title":"A combinatorial library of an alpha-helical bacterial receptor domain","volume":"8","author":"Nord","year":"1995","journal-title":"Protein Eng."},{"key":"10.1016\/j.envres.2023.116895_bib16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1053\/j.semnuclmed.2019.10.002","article-title":"Molecular imaging of infection: the first 50 years","volume":"50","author":"Palestro","year":"2020","journal-title":"Semin. Nucl. Med."},{"key":"10.1016\/j.envres.2023.116895_bib17","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1172\/JCI128699","article-title":"HVTN 105 Protocol Team and the NIAID HIV Vaccine Trials Network. DNA priming and gp120 boosting induces HIV-specific antibodies in a randomized clinical trial","volume":"129","author":"Rouphael","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.envres.2023.116895_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114700","article-title":"Oncogenic activity and cellular functionality of melanoma associated antigen A3","volume":"192","author":"Sch\u00e4fer","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.envres.2023.116895_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/jmr.2683","article-title":"Multispecificity of a recombinant anti-RAs monoclonal antibody","volume":"31","author":"Schrader","year":"2018","journal-title":"J. Mol. Recogn."},{"key":"10.1016\/j.envres.2023.116895_bib20","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13568-014-0082-3","article-title":"Inhibitory effects of H-Ras\/Raf-1-binding Affibody molecules on synovial cell function","volume":"4","author":"Shibasaki","year":"2014","journal-title":"Amb. Express"},{"key":"10.1016\/j.envres.2023.116895_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2018.03.026","article-title":"Cancer-germline antigen expression discriminates clinical outcome to CTLA-4 blockade","volume":"173","author":"Shukla","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.envres.2023.116895_bib22","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s12149-017-1164-5","article-title":"Comparison of 18F-FDG-PET\/CT and 18F-FDG-PET\/MR imaging in oncology: a systematic review","volume":"31","author":"Singnurkar","year":"2017","journal-title":"Ann. Nucl. Med."},{"key":"10.1016\/j.envres.2023.116895_bib23","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.3748\/wjg.v17.i46.5059","article-title":"Role of (18F) 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies","volume":"17","author":"Smyth","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.envres.2023.116895_bib24","doi-asserted-by":"crossref","first-page":"730","DOI":"10.2967\/jnumed.113.131243","article-title":"First-in-human molecular imaging of HER2 expression in breast cancer metastases using the 111In-ABY-025 Affibody molecule","volume":"55","author":"S\u00f6rensen","year":"2014","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.envres.2023.116895_bib25","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.tibtech.2017.04.007","article-title":"Affibody molecules in biotechnological and medical applications","volume":"35","author":"St\u00e5hl","year":"2017","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.envres.2023.116895_bib26","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1517\/14712598.7.4.555","article-title":"Affibody molecules: potential for in vivo imaging of molecular targets for cancer therapy","volume":"7","author":"Tolmachev","year":"2007","journal-title":"Expet Opin. Biol. Ther."},{"key":"10.1016\/j.envres.2023.116895_bib27","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1038\/s41598-018-24785-2","article-title":"Molecular design of radiocopper-labelled Affibody molecules","volume":"8","author":"Tolmachev","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.envres.2023.116895_bib28","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1126\/science.1840703","article-title":"A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma","volume":"254","author":"van der Bruggen","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.envres.2023.116895_bib29","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1200\/JCO.2012.43.7103","article-title":"Adjuvant MAGE-A3 immunotherapy in resected non-small-cell lung cancer: phase II randomized study results","volume":"31","author":"Vansteenkiste","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.envres.2023.116895_bib30","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S1470-2045(16)00099-1","article-title":"Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"17","author":"Vansteenkiste","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.envres.2023.116895_bib31","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1007\/s00253-019-09655-9","article-title":"A high-risk papillomavirus 18 E7 Affibody-enabled in vivo imaging and targeted therapy of cervical cancer","volume":"103","author":"Wang","year":"2019","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.envres.2023.116895_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ceb.2015.08.002","article-title":"The MACE protein family and cancer","volume":"37","author":"Weon","year":"2015","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.envres.2023.116895_bib33","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s13402-015-0261-5","article-title":"Melanoma associated antigen (MAGE)-A3 promotes cell proliferation and chemotherapeutic drug resistance in gastric cancer","volume":"39","author":"Xie","year":"2016","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.envres.2023.116895_bib34","doi-asserted-by":"crossref","first-page":"73995","DOI":"10.18632\/oncotarget.12174","article-title":"Generation of Affibody molecules specific for HPV16 E7 recognition","volume":"7","author":"Xue","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.envres.2023.116895_bib35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-1-4939-2272-7_3","article-title":"Getting across the cell membrane: an overview for small molecules, peptides, and proteins","volume":"1266","author":"Yang Nicole","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.envres.2023.116895_bib36","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.addr.2016.07.012","article-title":"Molecular imaging of the tumor microenvironment","volume":"113","author":"Zhou","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.envres.2023.116895_bib37","doi-asserted-by":"crossref","first-page":"7429","DOI":"10.1007\/s00253-018-9167-2","article-title":"Bispecific Affibody molecule targeting HPV16 and HPV18E7 oncoproteins for enhanced molecular imaging of cervical cancer","volume":"102","author":"Zhu","year":"2018","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.envres.2023.116895_bib38","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41419-020-2410-7","article-title":"Generation of novel Affibody molecules targeting the EBVLMP2AN-terminal domain with inhibiting effects on the proliferation of nasopharyngeal carcinoma cells","volume":"11","author":"Zhu","year":"2020","journal-title":"Cell Death Dis."}],"container-title":["Environmental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013935123016997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013935123016997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T03:05:38Z","timestamp":1762139138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0013935123016997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":38,"alternative-id":["S0013935123016997"],"URL":"https:\/\/doi.org\/10.1016\/j.envres.2023.116895","relation":{},"ISSN":["0013-9351"],"issn-type":[{"type":"print","value":"0013-9351"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel affibody molecules as potential agents in molecular imaging for MAGE-A3-positive tumor diagnosis","name":"articletitle","label":"Article Title"},{"value":"Environmental Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.envres.2023.116895","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116895"}}